Toward zero pancreatic fistula after pancreaticoduodenectomy with pancreaticogastrostomy

American Journal of Surgery

Volumn 191, Issue 6, 2006, Pages 733-734

  Brunicardi, F Charles ^a   Fisher, William E ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; GASTROSTOMY; HUMAN; MORBIDITY; PANCREAS FISTULA; PANCREAS RESECTION; PANCREATICODUODENECTOMY; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SURGICAL MORTALITY; SURGICAL TECHNIQUE;

EID: 33646752529     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2006.01.051     Document Type: Editorial

References (14)

1. Savarese L., Balestracci T., Sbrana F., et al. Histopathologic alterations of pancreatic slice after glandular section with the harmonic scalpel (Ultacision®). J Pancreas 2 suppl 5 (2001) 353-354
2. Bassi C., Butturni G., Molinari E., et al. Pancreatic fistula rate after pancreatic resection. The importance of definitions. Dig Surg 21 (2004) 54-59
3. Bassi C., Dervenis C., Butturini G., et al. Postoperative pancreatic fistula. an international study group (ISGPF) definition. Surgery 138 (2005) 8-13
4. Buchler M., Friess H., Klempa I., et al. Role of octreotide in the prevention of postoperative complications following pancreatic resection. Am J Surg 163 (1992) 125-131
5. Friess H., Beger H.G., Sulkowski U., et al. Randomized controlled multicentre study of the prevention of complications by octreotide in patients undergoing surgery for chronic pancreatitis. Br J Surg 82 (1995) 1270-1273
6. Pederzoli P., Bassi C., Falconi N., et al., Italian Study Group. Efficacy of octreotide in the prevention of complications of elective pancreatic surgery. Br J Surg 81 (1994) 265-269
7. Montorsi M., Zago M., Mosca F., et al. Efficacy of octreotide in the prevention of pancreatic fistula after elective pancreatic resections. a prospective, controlled, randomized clinical trial. Surgery (1995) 117-131
8. Lowy A.M., Lee J.E., Pisters P.W., et al. Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease. Ann Surg 226 (1997) 632-641
9. Yeo C.J., Cameron J.L., Lillemoe K.D., et al. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial. Ann Surg 232 (2000) 419-429
10. Barnett S.P., Hodul P.J., Creech S., et al. Octreotide does not prevent postoperative pancreatic fistula or mortality following pancreaticoduodenectomy. Am Surg 70 (2004) 222-226
11. Sarr M.G., and Pancreatic Surgery Group. The potent somatostatin analogue vapreotide does not decrease pancreas-specific complications after elective pancreatectomy. a prospective, multicenter, double-blinded, randomized, placebo-controlled trial. J Am Coll Surg 196 (2003) 556-564
12. D'Andrea A.A., Costantino V., Sperti C., et al. Human fibrin sealant in pancreatic surgery: is it useful in preventing fistulas? A prospective randomized study. Ital J Gastroenterol 26 (1994) 283-286
13. Kram H.B., Clark S.R., Ocampo H.P., et al. Fibrin glue sealing of pancreatic injuries, resections, and anastomosis. Am J Surg 161 (1991) 479-481
14. Yeo C.J., Cameron J.L., Maher M.M., et al. A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy. Ann Surg 222 (1995) 580-592